Abstract
This chapter describes one of the most remarkable characteristics of blood, its ability to clot. After a brief introduction relating to the history of blood coagulation research, which spans over 100 years, and the evolutionary mechanisms underlying coagulation systems, which indicate that some “ancestors” of coagulation factors were present over 400 million years ago, we discuss the two principal models of coagulation: cascade versus cell-based. Whereas the former has been the accepted model for over 30 years, the more recent cell-based model appears to be more applicable to in vivo blood coagulation. According to the latter model, platelet activation is a determinant event and can be induced either by thrombin produced as a consequence of the tissue factor/activated factor VII complex on cells bearing tissue factor, or by subendothelial collagen exposure. We then review the role played by endothelium and subendothelium structures in hemostasis and illustrate the relevance of tissue factor. The final sections are dedicated to platelet receptors and signaling pathways and to fibrinolysis, an important regulatory mechanism whose role is to start tissue damage repair, destroy the fibrin clot, restrain the clotting process, and prevent its extension into the vascular system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Davie EW (2003) A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem 278(51):50819–50832
Monroe DM, Hoffman M, Roberts HR (2007) Fathers of modern coagulation. Thromb Haemost 98:3–5
Davie EW, Ratnoff OD (1964) Waterfall sequence for intrinsic blood clotting. Science 145:1310–1312
MacFarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498–499
Roberts HR, Monroe DM, Oliver JA et al (1998) Newer concepts of blood coagulation. Haemophilia 4:331–334
Tanaka KA, Key NS, Levy JH (2009) Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 108:1433–1446
Davidson CJ, Hirt RP, Lal K et al (2003) Molecular evolution of the vertebrate blood coagulation network. Thromb Haemost 89:420–428
Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85:958–965
Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359:938–949
Bellido-Martin L, Chen V, Furie B, Furie BC (2011) Imaging fibrin formation and platelet and endothelial cell activation in vivo. Thromb Haemost 105:776–782
Savage B, Almus-Jacob F, Ruggeri ZM (1998) Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94:657–666
Ruggeri ZM (2009) Platelet adhesion under flow. Microcirculation 16(1):58–83
Rivera J, Lozano ML, Navarro-Núñez L, Vicente V (2009) Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94(5):700–711
Li Z, Delaney MK, O’Brien KA, Du X (2010) Signaling during platelet adhesion and activation. Arter Thromb Vasc Biol 30:2341–2349
Dubois C, Panicot-Dubois L, Gainor JF, Furie BC, Furie B (2007) Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest 117(4):953–960
Prandoni P (2007) Links between arterial and venous disease. J Intern Med 262(3):341–350
Roberts HR, Monroe DM, Escobar MA (2004) Current concepts of hemostasis. Anesthesiology 100:722–730
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265–9269
Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Jin RC, Voetsch B, Loscalzo J (2005) Endogenous mechanisms of inhibition of platelet function. Microcirculation 12:247–258
Esmon CT (2000) Regulation of blood coagulation. Biochim Biophys Acta 1477:349–360
Mann KG, Bovill EG, Krishnaswamy S (1991) Surface-dependent reactions in the propagation phase of blood coagulation. Ann N Y Acad Sci 614:63–75
Löwenberg EC, Meijers JCM, Levi M (2010) Platelet-vessel wall interaction in health and disease. Neth J Med 68:242–251
Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363–10370
Lippi G, Favaloro EJ, Franchini M, Guidi GC (2009) Milestones and perspectives in coagulation and hemostasis. Thromb Hemost 35:9–22
Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG (2005) Tissue factor activity in whole blood. Blood 105:2764–2770
George JN (2000) Platelets. Lancet 355:1531–1539
Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI (2006) Platelet expression profiling and clinical validation of myeloid-related protein 14 as a novel determinant of cardiovascular events. Circulation 113:2278–2284
Colucci M, Semeraro N (2006) Il sistema fibrinolitico. In: Burlina A (ed) Trattato italiano di medicina di laboratorio, vol 6. Piccin Nuova Libraria, Padua, pp 1–12
Nesheim M (2003) Thrombin and fibrinolysis. Chest 124:33S–39S
Clemetson KJ, Clemetson JM (2008) Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb Haemost 99:473–479
Kasirer-Friede A, Kahn ML, Shattil SJ (2007) Platelet integrins and immunoreceptors. Immunol Rev 218:247–264
Bennet JS (2005) Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 115(12):3363–3369
Clemetson KJ, Clemetson JM (2001) Platelet collagen receptors. Thromb Haemost 86:189–197
Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800–1814
Gachet C (2008) P2 receptors, platelet functions and pharmacological implications. Thromb Haemost 99:466–472
Smyth EM (2010) Thromboxane and the thromboxane receptor in cardiovascular disease. Clin Lipidol 5(2):209–219
Collen D, de Maeyer L (1975) Molecular biology of human plasminogen I. Physiochemical properties and microheterogeneity. Thromb Diath Haemorrh 34:396–402
Lin Z, Jiang L, Yuan C, Jensen JK, Zhang X, Luo Z, Furie BC, Furie B, Andreasen PA, Huang M (2011) Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem 286:7027–7032
Wind T, Hansen M, Jensen JK, Andreasen PA (2002) The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment. Biol Chem 383(1):21–36
Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114(5–6):409–414
Shaller J, Gerber SS (2011) The plasminplasmin-antiplasmin system: structural and functional aspects. Cell Mol Life Sci 68:785–801
Lijnen HR (2002) Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry 67:92–98
Tsurupa G, Yakovlev S, McKee P, Medved L (2010) Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites. Biochemistry 49(35):7643–7651
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Pradella, P., Tomasella, F., Mascaretti, L. (2012). Physiology of Hemostasis . In: Berlot, G. (eds) Hemocoagulative Problems in the Critically Ill Patient. Springer, Milano. https://doi.org/10.1007/978-88-470-2448-9_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-2448-9_1
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2447-2
Online ISBN: 978-88-470-2448-9
eBook Packages: MedicineMedicine (R0)